Analytic Investors’s John B. Sanfilippo & Son JBSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$2.19M Buy
42,701
+3,866
+10% +$186K 0.02% 261
2016
Q2
$1.66M Sell
38,835
-21,257
-35% -$1.16M 0.02% 305
2016
Q1
$4.15M Sell
60,092
-9,293
-13% -$580K 0.05% 221
2015
Q4
$3.75M Sell
69,385
-5,513
-7% -$311K 0.05% 220
2015
Q3
$3.84M Sell
74,898
-25,131
-25% -$1.3M 0.05% 211
2015
Q2
$5.19M Sell
100,029
-1,920
-2% -$96.1K 0.07% 167
2015
Q1
$4.39M Buy
101,949
+59,758
+142% +$2.31M 0.06% 174
2014
Q4
$1.92M Buy
42,191
+13,677
+48% +$536K 0.03% 256
2014
Q3
$923K Hold
28,514
0.01% 381
2014
Q2
$755K Sell
28,514
-6,902
-19% -$172K 0.01% 356
2014
Q1
$815K Sell
35,416
-254
-0.7% -$5.81K 0.01% 382
2013
Q4
$880K Hold
35,670
0.01% 321
2013
Q3
$827K Hold
35,670
0.01% 311
2013
Q2
$719K Buy
+35,670
New +$710K 0.01% 395

Other funds holding JBSS

Analytic Investors's JBSS Position: Q3 2016 in Review

Analytic Investors increased its John B. Sanfilippo & Son (JBSS) stake by 10% in Q3 2016, buying an estimated $186K and bringing the position to 42,701 shares worth $2.19M. The position accounts for 0.02% of the portfolio, ranked #261.

Analytic Investors first reported a position in JBSS in Q2 2013 and has held it in 14 quarters since. The position peaked at $5.19M in Q2 2015. 140 funds tracked by Wall St. Rank hold JBSS as of Q3 2016.

  • Analytic Investors held 42,701 shares of John B. Sanfilippo & Son worth $2.19M as of Q3 2016.
  • Analytic Investors bought 3,866 John B. Sanfilippo & Son shares in Q3 2016, an estimated $186K.
  • John B. Sanfilippo & Son made up 0.02% of Analytic Investors's portfolio in Q3 2016, its #261 holding.
  • Analytic Investors first reported a position in John B. Sanfilippo & Son in Q2 2013 and has held it in 14 quarters since.
  • Analytic Investors's John B. Sanfilippo & Son position peaked at $5.19M in Q2 2015.
  • 140 funds tracked by Wall St. Rank held John B. Sanfilippo & Son as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.